Clinical trial for Academic Anxiety
Official title AVE-Neurofeedback for Academic Anxiety and Divergent Thinking
ClinicalTrials.gov ID: NCT07745335
What this study is testing
- What it's testing
- Academic anxiety is one of the most prevalent psychological challenges among adolescents and has been associated with impaired executive functioning, attentional control, autonomic dysregulation, and reduced creative performance. Although neurofeedback and audiovisual entrainment have independently demonstrated beneficial effects on neural self-regulation, evidence regarding their integration within an adaptive closed-loop intervention remains limited.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 18. Healthy volunteers may be eligible.
You may be able to join if
- Senior high school students aged 15-18 years.
- Elevated academic anxiety according to screening assessment.
- Able to understand study procedures.
- Willing to provide written informed consent (and parental consent where required).
You likely can't join if
- History of epilepsy or seizure disorders.
- Neurological disorders.
- Severe psychiatric disorders.
- Current psychoactive medication affecting EEG activity.
- Significant visual impairment incompatible with photic stimulation.
- Previous neurofeedback training within the last six months.
The study team makes the final eligibility decision.
Where it's taking place
- Magelang, Central Java, Indonesia
- Nganjuk, East Java, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Magelang, Central Java, Indonesia; Nganjuk, East Java, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.